Mangrove Partners’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Mangrove Partners’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200,000	Closed	-$1.96M	–	641
2021 Q4	$1.96M	Hold	200,000	–	–	0.12%	322
2021 Q3	$1.95M	Buy	200,000 +17,800	+10%	+$172K	0.17%	227
2021 Q2	$1.76M	Buy	182,200 +62,600	+52%	+$609K	0.18%	201
2021 Q1	$1.15M	Buy	+119,600	New	+$1.16M	0.12%	177

Other funds holding SHAC

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Mangrove Partners's SHAC Position: Q1 2022 in Review

Mangrove Partners sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q1 2022, closing a stake of 200,000 shares — an estimated $1.96M sold.

Mangrove Partners first reported a position in SHAC in Q1 2021 and held it in 4 quarters. The position peaked at $1.96M in Q4 2021. 68 funds tracked by Wall St. Rank hold SHAC as of Q1 2022.

Mangrove Partners reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q1 2022 after selling out during the quarter.
Mangrove Partners sold 200,000 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q1 2022, an estimated $1.96M.
Mangrove Partners first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 4 quarters.
Mangrove Partners's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $1.96M in Q4 2021.
68 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.